Joris Wit

Joris Wit, Angel investor in Leuven is an active investor based in Leuven, Flanders. This profile covers what Joris Wit backs, at which stage, and how founders can reach out in 2026.

Dr. Joris De Wit is a Scientific Co-Founder and serves as Member of Scientific Advisory Board at Augustine. He split his postdoctoral training between Amsterdam with Matthijs Verhage (VU Amsterdam) from 2004 to 2006, and San Diego, USA with Anirvan Ghosh (University of California San Diego) from 2006 to 2012. In 2013, he started the Laboratory of Synapse Biology at the VIB-KU Leuven Center for Brain & Disease Research and became Associate Professor at KU Leuven. In 2019, he was promoted to Professor at the Neurosciences Department. He is the recipient of an ERC Starting Grant and FWO Odysseus grant. Work from his lab includes the discovery of a new sorting mechanism by which neurons regulate the protein composition of their cell surface and the identification of molecular adhesion codes that specify properties of specific synapses. The discovery of a new role for the secreted amyloid precursor protein in modulating synaptic transmission, in close collaboration with the laboratory of Dr. Bart De Strooper, was published in Science in 2019, and forms the basis of one of the projects being pursued by Augustine Therapeutics.